These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38109684)

  • 1. Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study.
    Sarkozy C; Thieblemont C; Oberic L; Moreau A; Bouabdallah K; Damaj G; Gastinne T; Tessoulin B; Ribrag V; Casasnovas O; Haioun C; Houot R; Jardin F; Van Den Neste E; Cheminant M; Morschhauser F; Callanan M; Safar V; Gressin R; Hermine O; Le Gouill S
    J Clin Oncol; 2024 Mar; 42(7):769-773. PubMed ID: 38109684
    [No Abstract]   [Full Text] [Related]  

  • 2. High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.
    Hermine O; Jiang L; Walewski J; Bosly A; Thieblemont C; Szymczyk M; Pott C; Salles G; Feugier P; Hübel K; Haioun C; Casasnovas RO; Schmidt C; Bouabdallah K; Ribrag V; Kanz L; Dürig J; Metzner B; Sibon D; Cheminant M; Burroni B; Klapper W; Hiddemann W; Unterhalt M; Hoster E; Dreyling M;
    J Clin Oncol; 2023 Jan; 41(3):479-484. PubMed ID: 36469833
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial.
    Zoellner AK; Unterhalt M; Stilgenbauer S; Hübel K; Thieblemont C; Metzner B; Topp M; Truemper L; Schmidt C; Bouabdallah K; Krauter J; Lenz G; Dürig J; Vergote V; Schäfer-Eckart K; André M; Kluin-Nelemans HC; van Hoof A; Klapper W; Hiddemann W; Dreyling M; Hoster E;
    Lancet Haematol; 2021 Sep; 8(9):e648-e657. PubMed ID: 34450102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma.
    Bouard L; Tessoulin B; Thieblemont C; Bouabdallah K; Gastinne T; Oberic L; Carras S; Delette C; Casasnovas O; Dartigeas C; Cacheux V; Masse S; Hermine O; Le Gouill S
    Haematologica; 2022 Sep; 107(9):2163-2172. PubMed ID: 35172560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
    Le Gouill S; Thieblemont C; Oberic L; Moreau A; Bouabdallah K; Dartigeas C; Damaj G; Gastinne T; Ribrag V; Feugier P; Casasnovas O; Zerazhi H; Haioun C; Maisonneuve H; Houot R; Jardin F; Van Den Neste E; Tournilhac O; Le Dû K; Morschhauser F; Cartron G; Fornecker LM; Canioni D; Callanan M; Béné MC; Salles G; Tilly H; Lamy T; Gressin R; Hermine O;
    N Engl J Med; 2017 Sep; 377(13):1250-1260. PubMed ID: 28953447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta-analysis.
    Hilal T; Wang Z; Almader-Douglas D; Rosenthal A; Reeder CB; Jain T
    Am J Hematol; 2018 Oct; 93(10):1220-1226. PubMed ID: 30033656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial.
    Tessoulin B; Chiron D; Thieblemont C; Oberic L; Bouadballah K; Gyan E; Damaj G; Ribrag V; Gressin R; Feugier P; Casasnovas O; Zerazhi H; Lemonnier F; Maisonneuve H; Joubert C; Van Den Neste E; Lamy T; Tilly H; Moreau A; Hermine O; Le Gouill S
    Bone Marrow Transplant; 2021 Jul; 56(7):1700-1709. PubMed ID: 33658645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era.
    Gerson JN; Handorf E; Villa D; Gerrie AS; Chapani P; Li S; Medeiros LJ; Wang MI; Cohen JB; Calzada O; Churnetski MC; Hill BT; Sawalha Y; Hernandez-Ilizaliturri FJ; Kothari S; Vose JM; Bast MA; Fenske TS; Narayana Rao Gari S; Maddocks KJ; Bond D; Bachanova V; Kolla B; Chavez J; Shah B; Lansigan F; Burns TF; Donovan AM; Wagner-Johnston N; Messmer M; Mehta A; Anderson JK; Reddy N; Kovach AE; Landsburg DJ; Glenn M; Inwards DJ; Karmali R; Kaplan JB; Caimi PF; Rajguru S; Evens A; Klein A; Umyarova E; Pulluri B; Amengual JE; Lue JK; Diefenbach C; Fisher RI; Barta SK
    J Clin Oncol; 2019 Feb; 37(6):471-480. PubMed ID: 30615550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R
    Morschhauser F; Nastoupil L; Feugier P; Schiano de Colella JM; Tilly H; Palomba ML; Bachy E; Fruchart C; Libby EN; Casasnovas RO; Flinn IW; Haioun C; Maisonneuve H; Ysebaert L; Bartlett NL; Bouabdallah K; Brice P; Ribrag V; Le Gouill S; Daguindau N; Guidez S; Pica GM; García-Sancho AM; López-Guillermo A; Larouche JF; Ando K; Gomes da Silva M; André M; Kalung W; Sehn LH; Izutsu K; Cartron G; Gkasiamis A; Crowe R; Xerri L; Fowler NH; Salles G
    J Clin Oncol; 2022 Oct; 40(28):3239-3245. PubMed ID: 35947804
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab.
    Mei MG; Cao TM; Chen L; Song JY; Siddiqi T; Cai JL; Farol LT; Al Malki MM; Salhotra A; Aldoss I; Palmer J; Herrera AF; Zain J; Popplewell LL; Chen RW; Rosen ST; Forman SJ; Kwak L; Nademanee AP; Budde LE
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1861-1869. PubMed ID: 28733266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience.
    Bourcier J; Gastinne T; Leux C; Moreau A; Bossard C; Mahé B; Blin N; Dubruille V; Touzeau C; Voldoire M; Guillaume T; Peterlin P; Gallas P; Garnier A; Maisonneuve H; Moreau P; Juge-Morineau N; Jardel H; Chevallier P; Moreau P; Le Gouill S
    Ann Hematol; 2016 Aug; 95(8):1287-93. PubMed ID: 27297970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation.
    Chen RW; Palmer JM; Tomassetti S; Popplewell LL; Alluin J; Chomchan P; Nademanee AP; Siddiqi T; Tsai NC; Chen L; Zuo F; Abary R; Cai JL; Herrera AF; Rossi JJ; Rosen ST; Forman SJ; Kwak LW; Holmberg LA
    J Hematol Oncol; 2018 Jun; 11(1):87. PubMed ID: 29954415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial.
    Ladetto M; Cortelazzo S; Ferrero S; Evangelista A; Mian M; Tavarozzi R; Zanni M; Cavallo F; Di Rocco A; Stefoni V; Pagani C; Re A; Chiappella A; Balzarotti M; Zilioli VR; Gomes da Silva M; Arcaini L; Molinari AL; Ballerini F; Ferreri AJM; Puccini B; Benedetti F; Stefani PM; Narni F; Casaroli I; Stelitano C; Ciccone G; Vitolo U; Martelli M
    Lancet Haematol; 2021 Jan; 8(1):e34-e44. PubMed ID: 33357480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma.
    Sarkozy C; Callanan M; Thieblemont C; Obéric L; Burroni B; Bouabdallah K; Damaj G; Tessoulin B; Ribrag V; Houot R; Morschhauser F; Griolet S; Joubert C; Cacheux V; Delwail V; Safar V; Gressin R; Cheminant M; Delfau-Larue MH; Hermine O; Macintyre E; Le Gouill S
    Blood; 2024 Jul; 144(3):262-271. PubMed ID: 38669626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
    Kolstad A; Pedersen LB; Eskelund CW; Husby S; Grønbæk K; Jerkeman M; Laurell A; Räty R; Elonen E; Andersen NS; Brown PD; Kimby E; Bentzen H; Sundström C; Ehinger M; Karjalainen-Lindsberg ML; Delabie J; Ralfkiær E; Fagerli UM; Nilsson-Ehle H; Lauritzsen GF; Kuittinen O; Niemann C; Geisler CH;
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):428-435. PubMed ID: 28039078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma.
    Kahl BS; Jegede OA; Peterson C; Swinnen LJ; Habermann TM; Schuster SJ; Weiss M; Fishkin PA; Fenske TS; Williams ME
    J Clin Oncol; 2024 Mar; 42(7):774-778. PubMed ID: 38194625
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study.
    Houillier C; Dureau S; Taillandier L; Houot R; Chinot O; Moluçon-Chabrot C; Schmitt A; Gressin R; Choquet S; Damaj G; Peyrade F; Abraham J; Delwail V; Gyan E; Sanhes L; Cornillon J; Garidi R; Delmer A; Al Jijakli A; Morel P; Waultier A; Paillassa J; Chauchet A; Gastinne T; Laadhari M; Plissonnier AS; Feuvret L; Cassoux N; Touitou V; Ricard D; Hoang-Xuan K; Soussain C;
    J Clin Oncol; 2022 Nov; 40(32):3692-3698. PubMed ID: 35834762
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.
    Federico M; Fortpied C; Stepanishyna Y; Gotti M; van der Maazen R; Cristinelli C; Re A; Plattel W; Lazarovici J; Merli F; Specht L; Schiano de Colella JM; Hutchings M; Versari A; Edeline V; Stamatoulas A; Girinsky T; Ricardi U; Aleman B; Meulemans B; Tonino S; Raemaekers J; André M
    J Clin Oncol; 2024 Jan; 42(1):19-25. PubMed ID: 37967311
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cytarabine and hematopoietic cell transplantation for mantle cell lymphoma. Analysis of 20 patients].
    Campbell J; Hurtado S; Kutz C; Soto K; Ernst D
    Rev Med Chil; 2019; 147(1):9-17. PubMed ID: 30848759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.